Recent Finacing
Recent Raise
RedShift BioAnalytics develops Microfluidic Modulation Spectroscopy (MMS) instruments, including the AQS3pro infrared platform, to measure protein secondary structure, quantitation, stability, aggregation and similarity for biotherapeutic R&D and quality control.
